Pharmaceutical agents and pregnancy in urology practice.

Author(s): Shrim A, Garcia-Bournissen F, Koren G

Affiliation(s): The Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hospital for Sick Children, The University of Toronto, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.

Publication date & source: 2007-02, Urol Clin North Am., 34(1):27-33.

Publication type: Research Support, Non-U.S. Gov't; Review

Urologic medical conditions are not frequently encountered during pregnancy. Still, urologists often are asked to treat pregnant patients for conditions that require prescriptions. In the generally healthy population of pregnant women, the use of pharmaceutical agents is usually reserved for women who have either infections or necessary surgical procedures. This article addresses the implications for pregnancy of common urologic conditions in generally healthy pregnant women, namely simple urinary tract infections that demand nitrofurantoin and complex urinary tract infections that necessitate fluoroquinolones treatment. It also examines the implications of nonobstetric surgical intervention.